- Home
- EPIX vs STHO Comparison
EPIX vs STHO Comparison
Compare EPIX & STHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPIX
- STHO
- Stock Information
- Founded
- EPIX 2009
- STHO N/A
- Country
- EPIX Canada
- STHO United States
- Employees
- EPIX N/A
- STHO N/A
- Industry
- EPIX Biotechnology: Pharmaceutical Preparations
- STHO Real Estate
- Sector
- EPIX Health Care
- STHO Real Estate
- Exchange
- EPIX Nasdaq
- STHO Nasdaq
- Market Cap
- EPIX 75.9M
- STHO 89.7M
- IPO Year
- EPIX N/A
- STHO N/A
- Fundamental
- Price
- EPIX $1.87
- STHO $7.57
- Analyst Decision
- EPIX Hold
- STHO
- Analyst Count
- EPIX 3
- STHO 0
- Target Price
- EPIX $2.00
- STHO N/A
- AVG Volume (30 Days)
- EPIX 452.3K
- STHO 55.3K
- Earning Date
- EPIX 08-04-2025
- STHO 08-05-2025
- Dividend Yield
- EPIX N/A
- STHO N/A
- EPS Growth
- EPIX N/A
- STHO N/A
- EPS
- EPIX N/A
- STHO N/A
- Revenue
- EPIX N/A
- STHO $113,297,000.00
- Revenue This Year
- EPIX N/A
- STHO N/A
- Revenue Next Year
- EPIX N/A
- STHO N/A
- P/E Ratio
- EPIX N/A
- STHO N/A
- Revenue Growth
- EPIX N/A
- STHO N/A
- 52 Week Low
- EPIX $1.40
- STHO $6.06
- 52 Week High
- EPIX $7.88
- STHO $14.50
- Technical
- Relative Strength Index (RSI)
- EPIX 63.77
- STHO 44.98
- Support Level
- EPIX $1.86
- STHO $7.68
- Resistance Level
- EPIX $1.88
- STHO $8.09
- Average True Range (ATR)
- EPIX 0.02
- STHO 0.22
- MACD
- EPIX 0.00
- STHO -0.07
- Stochastic Oscillator
- EPIX 94.74
- STHO 4.35
About EPIX ESSA Pharma Inc.
ESSA Pharma Inc is a pharmaceutical company. The company was focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It was developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival. Currently, the company has terminated its clinical trials and other studies.
About STHO Star Holdings Shares of Beneficial Interest
Star Holdings engages in non-ground lease-related businesses, including real estate finance, operating properties, and land and development. Its portfolio is comprised of its interests in Asbury and Magnolia Green residential development projects, a portfolio of commercial real estate properties, and loans that are being marketed for sale. The Company operates its business through one reportable and operating segment that focuses on realizing value for shareholders by generating cash flows through active asset management and sales of its existing loans, operating properties and land and development properties.